LSD for anxiety and psychedelic clinical trials with MindMed CMO, Dr. Daniel Karlin - podcast episode cover

LSD for anxiety and psychedelic clinical trials with MindMed CMO, Dr. Daniel Karlin

Jun 06, 202356 minEp. 104
--:--
--:--
Listen in podcast apps:

Episode description

Send us a text

In today’s episode of the Psychedelic Therapy Frontiers podcast Dr. Steve Thayer and Dr. Reid Robison are joined by Dr. Dan Karlin. Dan is Board Certified in Psychiatry, Addiction Medicine, and Clinical Informatics. He currently serves as the Chief Medical Officer of MindMed, a drug development company striving to deliver on the therapeutic potential of psychedelics to address unmet patient needs in psychiatry, addiction, pain, and neurology. Numinus is a trial site for MindMed’s MM-120 or LSD dose-finding study for the treatment of anxiety symptoms, so they discuss that study and what LSD treatment might look like in a post-approval clinical context. They discuss the challenges of mental health care accessibility and affordability, explore the philosophy behind the psychiatric diagnostic system, talk about the societal burden of anxiety, compare and contrast anxiety vs depression, and much more.

Come and attend the MAPS Psychedelic Science 2023 conference, Numinus is offering an exclusive 20% discount code to our PTF Podcast listeners. To get 20% off the  registration price, click this link (https://bit.ly/3kzoofk) and use the code NWI20 at checkout.

Learn more about our psychedelic training programs at HERE and use code PTF10 at checkout for 10% off! 

(2:35) Dr. Dan Karlin introduces himself and psychedelic studies
(13:34) The path to psychedelic approval
(16:37) Why anxiety?
(21:42) Why LSD?
(24:51) MM-120 and accessibility
(33:21) The burden of anxiety in society
(50:44) MindMed updates

Learn more about our podcast at https://numinus.com/podcast/
Learn more about psychedelic therapy training opportunities at https://numinus.com/training/
Learn more about our clinical trials at https://www.numinus.com/clinical-trials
Learn more about Numinus at https://numinus.com/

Email us at [email protected]

Follow us on Instagram:
https://www.instagram.com/drstevethayer/
https://www.instagram.com/innerspacedoctor/
https://www.instagram.com/numinushealth/

LSD for anxiety and psychedelic clinical trials with MindMed CMO, Dr. Daniel Karlin | Psychedelic Therapy Frontiers podcast - Listen or read transcript on Metacast